COVID-19 patients at two area hospitals first to receive trial nasal spray of antiviral drug remdesivir

Researchers at Baylor Scott & White are the first worldwide to try a new way to administer the antiviral drug remdesivir, which has been tested to help…

Read the full article here

Related Articles